Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Classifica tra le azioni #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Prezzo delle azioni
$41.14
Ultima sincronizzazione: 2026-09-21
Capitalizzazione di mercato
$182.76B
Variazione (1 giorno)
-7.78%
Variazione (1 anno)
-32.24%
Paese
DK
Scambia Novo Nordisk A/S (NOVO-B)

Categoria

Rapporto P/S per Novo Nordisk A/S (NOVO-B)
Rapporto P/S al September 2026 TTM: 3.78
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Novo Nordisk A/S, il rapporto P/S attuale (TTM) è 3.78. Alla fine del 2024, era pari a 9.57.
Storico del rapporto P/S per Novo Nordisk A/S da 2000 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 3.78 -19.20%
2025 4.68 -51.16%
2024 9.57 -28.95%
2023 13.47 12.21%
2022 12.01 0.14%
2021 11.99 52.88%
2020 7.84 4.26%
2019 7.52 14.27%
2018 6.58 -10.96%
2017 7.39 28.28%
2016 5.76 -39.48%
2015 9.53 23.95%
2014 7.69 20.58%
2013 6.37 -2.85%
2012 6.56 16.63%
2011 5.62 -6.38%
2010 6.01 54.26%
2009 3.89 6.22%
2008 3.67 -25.10%
2007 4.90 23.93%
2006 3.95 14.37%
2005 3.45 -0.13%
2004 3.46 11.99%
2003 3.09 9.60%
2002 2.82 -43.18%
2001 4.96 6.86%
2000 4.64 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
13.45 255.68%
US
6.55 73.32%
US
7.18 89.91%
US
4.66 23.19%
CH
5.39 42.48%
US